Complete Pathological Response Following Neoadjuvant FOLFIRINOX in Borderline Resectable Pancreatic Cancer - A Case Report and Review
BMC Cancer - United Kingdom
doi 10.1186/s12885-016-2821-0
Full Text
Open PDFAbstract
Available in full text
Date
October 10, 2016
Authors
Publisher
Springer Science and Business Media LLC